PRONZATO, PAOLO

PRONZATO, PAOLO  

170011 - UNIVERSITA' DEGLI STUDI DI GENOVA  

Mostra records
Risultati 1 - 20 di 28 (tempo di esecuzione: 0.049 secondi).
Titolo Data di pubblicazione Autore(i) File
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 1-gen-2016 Del Mastro, L; Levaggi, A; Michelotti, A; Cavazzini, G; Adami, Francesca; Scotto, T; Piras, M; Danese, S; Garrone, O; Durando, A; Accortanzo, V; Bighin, C; Miglietta, L; Pastorino, S; Pronzato, P; Castiglione, F; Landucci, E; Conte, Pierfranco; Bruzzi, P
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research Activities 1-gen-2020 Poggio, Francesca; Tagliamento, Marco; Di Maio, Massimo; Martelli, Valentino; De Maria, Andrea; Barisione, Emanuela; Grosso, Marco; Boccardo, Francesco; Pronzato, Paolo; Del Mastro, Lucia; Lambertini, Matteo
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients 1-gen-2022 Marconi, Silvia; Croce, Michela; Chiorino, Giovanna; Rossi, Giovanni; Guana, Francesca; Profumo, Aldo; Ostano, Paola; Alama, Angela; Longo, Luca; De Luca, Giuseppa; Dono, Mariella; Dal Bello, Maria Giovanna; Ponassi, Marco; Rosano, Camillo; Romano, Paolo; Cavalieri, Zita; Grassi, Massimiliano; Tagliamento, Marco; Zullo, Lodovica; Venturi, Consuelo; Dellepiane, Chiara; Mastracci, Luca; Bennicelli, Elisa; Pronzato, Paolo; Genova, Carlo; Coco, Simona
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 1-gen-2017 Poggio, F.; Ceppi, M.; Lambertini, M.; Bruzzi, P.; Ugolini, D.; Bighin, C.; Levaggi, A.; Giraudi, S.; D'Alonzo, A.; Vaglica, M.; Blondeaux, E.; Sertoli, M. R.; Pronzato, P.; Del Mastro, L.
Economic Impact of Inter-Regional Health Mobility In The Oldest European Administrative Region: A Starting Point For Changing Organizational Model? 1-gen-2018 Paleari, Laura; Paganino, Chiara; Paolo, Romairone; Amicizia, Daniela; Paoli, Gabriella; Pronzato, Paolo; Walter, Locatelli; Ansaldi, Filippo; Andrea, Decensi
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. 1-gen-2011 Del Mastro, L; Boni, L; Michelotti, A; Gamucci, T; Olmeo, N; Gori, S; Giordano, M; Garrone, O; Pronzato, P; Bighin, C; Levaggi, A; Giraudi, S; Cresti, N; Magnolfi, E; Scotto, T; Vecchio, C; Venturini, M.
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: Extending endocrine sensitivity 1-gen-2020 Frassoldati, A.; Biganzoli, L.; Bordonaro, R.; Cinieri, S.; Conte, P.; Laurentis, M. D.; Mastro, L. D.; Gori, S.; Lauria, R.; Marchetti, P.; Michelotti, A.; Montemurro, F.; Naso, G.; Pronzato, P.; Puglisi, F.; Tondini, C. A.
Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors 1-gen-2010 Bighin, C; Lunardi, G; Del Mastro, L; Marroni, P; Taveggia, P; Levaggi, A; Giraudi, S; Pronzato, P
Experience with a nurse-driven genetic counseling pathway of Italian women with uninformative BRCA test result 1-gen-2022 Blondeaux, Eva; Lambertini, Matteo; Buzzatti, Giulia; Bruzzone, Carla; Baraga, Marina; Pisani, Roberta; Del Mastro, Lucia; Pronzato, Paolo; Varesco, Liliana; Bonelli, Luigina
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: Results of an observational study 1-gen-2017 Bighin, Claudia; Dozin, Beatrice; Poggio, Francesca; Ceppi, Marcello; Bruzzi, Paolo; D'Alonzo, Alessia; Levaggi, Alessia; Giraudi, Sara; Lambertini, Matteo; Miglietta, Loredana; Vaglica, Marina; Fontana, Vincenzo; Iacono, Giuseppina; Pronzato, Paolo; Del Mastro, Lucia
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives 1-gen-2022 Cella, Eugenia; Zullo, Lodovica; Marconi, Silvia; Rossi, Giovanni; Coco, Simona; Dellepiane, Chiara; Alama, Angela; Rozeboom, Leslie; Bennicelli, Elisa; Parisi, Francesca; Sacco, Gianluca; Barletta, Giulia; Zinoli, Linda; Tagliamento, Marco; Pronzato, Paolo; Genova, Carlo
The Impact of the Introduction of the Breast Unit Model in a Northwestern Italian Region 1-gen-2022 Paleari, L.; Tassinari, F.; Astengo, M.; Amicizia, D.; Paganino, C.; Paoli, G.; Pronzato, P.; Ansaldi, F.
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 1-gen-2020 Cazzaniga, M. E.; Verusio, C.; Ciccarese, M.; Fumagalli, A.; Sartori, D.; Valerio, M. R.; Airoldi, M.; Moretti, G.; Ficorella, C.; Vernazza, Gianni; Michelotti, A.; Zambelli, A.; Febbraro, A.; Generali, D.; Pistelli, M.; Garrone, O.; Musolino, A.; Vici, P.; Maur, M.; Mentuccia, L.; La Verde, N.; Bianchi, G. V.; Artale, S.; Blasi, L.; De Laurentiis, M.; Atzori, F.; Turletti, A.; Porpiglia, M.; Santini, D.; Fabi, A.; Gebbia, V.; Schirone, A.; Palumbo, R.; Ferzi, A.; Frassoldati, A.; Scavelli, C.; Clivio, L.; Giordano, M.; Donadio, M.; Biganzoli, L.; Del Mastro, L.; Bisagni, G.; Livi, L.; Natoli, C.; Montemurro, F.; Riccardi, F.; Romagnoli, E.; Marchetti, P.; Torri, V.; Pronzato, P.; Mustacchi, G.
Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: current role and future perspectives 1-gen-2011 Del Mastro, L; Levaggi, A; Giraudi, S; Pronzato, P
Medical approaches to preservation of fertility in female cancer patients 1-gen-2011 Del Mastro, L; Giraudi, S; Levaggi, A; Pronzato, P
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast malignancies: a systematic review and meta-analysis 1-gen-2021 Tagliamento, Marco; Agostinetto, Elisa; Bruzzone, Marco; Ceppi, Marcello; Saini, Kamal S; de Azambuja, Evandro; Punie, Kevin; Westphalen, C Benedikt; Morgan, Gilberto; Pronzato, Paolo; Del Mastro, Lucia; Poggio, Francesca; Lambertini, Matteo
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients 1-gen-2016 Del Mastro, L; Rossi, Giovanni; Lambertini, M; Poggio, F; Pronzato, P
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 1-gen-2018 Conte, P.; Frassoldati, A.; Bisagni, G.; Brandes, A. A.; Donadio, M.; Garrone, O.; Piacentini, F.; Cavanna, L.; Giotta, F.; Aieta, M.; Gebbia, V.; Molino, A.; Musolino, A.; Ferro, A.; Maltoni, R.; Danese, S.; Zamagni, C.; Rimanti, A.; Cagossi, K.; Russo, A.; Pronzato, P.; Giovanardi, F.; Moretti, G.; Lombardo, L.; Schirone, A.; Beano, A.; Amaducci, L.; Bajardi, E. A.; Vicini, R.; Balduzzi, S.; D'Amico, R.; Guarneri, V.
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial 1-gen-2015 Lambertini, M; Boni, L; Michelotti, A; Gamucci, T; Scotto, T; Gori, S; Giordano, M; Garrone, O; Levaggi, A; Poggio, F; Giraudi, S; Bighin, C; Vecchio, C; Sertoli, Mr; Pronzato, P; Del Mastro, L
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial 1-gen-2016 Lambertini, M; Bruzzi, P; Poggio, F; Pastorino, S; Gardin, G; Clavarezza, Matteo; Bighin, C; Pronzato, P; Del Mastro, L